25 related articles for article (PubMed ID: 8568799)
1. Design, Synthesis and Biological Evaluation of Novel N-Arylpiperazines Containing a 4,5-Dihydrothiazole Ring.
Andreozzi G; Ambrosio MR; Magli E; Maneli G; Severino B; Corvino A; Sparaco R; Perissutti E; Frecentese F; Santagada V; Leśniak A; Bujalska-Zadrożny M; Caliendo G; Formisano P; Fiorino F
Pharmaceuticals (Basel); 2023 Oct; 16(10):. PubMed ID: 37895954
[TBL] [Abstract][Full Text] [Related]
2. In Silico Studies Targeting G-protein Coupled Receptors for Drug Research Against Parkinson's Disease.
Lemos A; Melo R; Preto AJ; Almeida JG; Moreira IS; Dias Soeiro Cordeiro MN
Curr Neuropharmacol; 2018; 16(6):786-848. PubMed ID: 29521236
[TBL] [Abstract][Full Text] [Related]
3. From Homology Models to a Set of Predictive Binding Pockets-a 5-HT
Warszycki D; Rueda M; Mordalski S; Kristiansen K; Satała G; Rataj K; Chilmonczyk Z; Sylte I; Abagyan R; Bojarski AJ
J Chem Inf Model; 2017 Feb; 57(2):311-321. PubMed ID: 28055203
[TBL] [Abstract][Full Text] [Related]
4. 5-HT1A receptor pharmacophores to screen for off-target activity of α1-adrenoceptor antagonists.
Ngo T; Nicholas TJ; Chen J; Finch AM; Griffith R
J Comput Aided Mol Des; 2013 Apr; 27(4):305-19. PubMed ID: 23625023
[TBL] [Abstract][Full Text] [Related]
5. An overview on GPCRs and drug discovery: structure-based drug design and structural biology on GPCRs.
Lundstrom K
Methods Mol Biol; 2009; 552():51-66. PubMed ID: 19513641
[TBL] [Abstract][Full Text] [Related]
6. 3D-QSAR using 'multiconformer' alignment: the use of HASL in the analysis of 5-HT1A thienopyrimidinone ligands.
Guccione S; Doweyko AM; Chen H; Barretta GU; Balzano F
J Comput Aided Mol Des; 2000 Oct; 14(7):647-57. PubMed ID: 11008886
[TBL] [Abstract][Full Text] [Related]
7. Localization and quantification of hydrophobicity: the molecular free energy density (MolFESD) concept and its application to sweetness recognition.
Jäger R; Schmidt F; Schilling B; Brickmann J
J Comput Aided Mol Des; 2000 Oct; 14(7):631-46. PubMed ID: 11008885
[TBL] [Abstract][Full Text] [Related]
8. A synthetic overview of new molecules with 5-HT1A binding affinities.
Pessoa-Mahana H; Araya-Maturana R; Saitz CB; Pessoa-Mahana DC
Mini Rev Med Chem; 2003 Mar; 3(2):77-93. PubMed ID: 12570842
[TBL] [Abstract][Full Text] [Related]
9. (Hetero)Aryloxyaminopropanols with N-Phenylpiperazine Structural Fragment - Review of Cardiovascular Activity.
Marvanova P; Padrtova T; Mokry P
Mini Rev Med Chem; 2020; 20(17):1719-1731. PubMed ID: 32579495
[TBL] [Abstract][Full Text] [Related]
10. Binding of arylpiperazines, (aryloxy)propanolamines, and tetrahydropyridylindoles to the 5-HT1A receptor: contribution of the molecular lipophilicity potential to three-dimensional quantitative structure-affinity relationship models.
Gaillard P; Carrupt PA; Testa B; Schambel P
J Med Chem; 1996 Jan; 39(1):126-34. PubMed ID: 8568799
[TBL] [Abstract][Full Text] [Related]
11. Synthesis and structure-activity relationships of a new model of arylpiperazines. 4. 1-[omega-(4-Arylpiperazin-1-yl)alkyl]-3-(diphenylmethylene) - 2, 5-pyrrolidinediones and -3-(9H-fluoren-9-ylidene)-2, 5-pyrrolidinediones: study of the steric requirements of the terminal amide fragment on 5-HT1A affinity/selectivity.
López-Rodríguez ML; Morcillo MJ; Rovat TK; Fernández E; Vicente B; Sanz AM; Hernández M; Orensanz L
J Med Chem; 1999 Jan; 42(1):36-49. PubMed ID: 9888831
[TBL] [Abstract][Full Text] [Related]
12. New sigma and 5-HT1A receptor ligands: omega-(tetralin-1-yl)-n-alkylamine derivatives.
Berardi F; Colabufo NA; Giudice G; Perrone R; Tortorella V; Govoni S; Lucchi L
J Med Chem; 1996 Jan; 39(1):176-82. PubMed ID: 8568804
[TBL] [Abstract][Full Text] [Related]
13. 5-HT1A-versus D2-receptor selectivity of flesinoxan and analogous N4-substituted N1-arylpiperazines.
Kuipers W; Kruse CG; van Wijngaarden I; Standaar PJ; Tulp MT; Veldman N; Spek AL; IJzerman AP
J Med Chem; 1997 Jan; 40(3):300-12. PubMed ID: 9022796
[TBL] [Abstract][Full Text] [Related]
14. Arylpiperazines with serotonin-3 antagonist activity: a comparative molecular field analysis.
Morreale A; Gálvez-Ruano E; Iriepa-Canalda I; Boyd DB
J Med Chem; 1998 Jun; 41(12):2029-39. PubMed ID: 9622544
[TBL] [Abstract][Full Text] [Related]
15. Synthesis and structure-activity relationships of a new model of arylpiperazines. 3.1 2-[omega-(4-arylpiperazin-1-yl)alkyl]perhydropyrrolo- [1,2-c]imidazoles and -perhydroimidazo[1,5-a]pyridines: study of the influence of the terminal amide fragment on 5-HT1A affinity/selectivity.
López-Rodríguez ML; Morcillo MJ; Fernández E; Porras E; Murcia M; Sanz AM; Orensanz L
J Med Chem; 1997 Aug; 40(16):2653-6. PubMed ID: 9258372
[TBL] [Abstract][Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
